Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

Preemptive antiviral therapy with entecavir can reduce acute deterioration of hepatic function following transarterial chemoembolization

Sun Hong Yoo, Jeong Won Jang, Jung Hyun Kwon, Seung Min Jung, Bohyun Jang, Jong Young Choi

Clin Mol Hepatol. 2016;22(4):458-465. Published online December 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0054

View: 8766 Download: 134 Web of Science: 9 Crossref: 9

Rescue therapy with adefovir in decompensated liver cirrhosis patients with lamivudine-resistant hepatitis B virus

Hyun Young Woo, Jong Young Choi, Seung Kew Yoon, Dong Jin Suh, Seung Woon Paik, Kwang Hyub Han, Soon Ho Um, Byung Ik Kim, Heon Ju Lee, Mong Cho, Chun Kyon Lee, Dong Joon Kim, Jae Seok Hwang

Clin Mol Hepatol. 2014;20(2):168-176. Published online June 30, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.2.168

View: 8062 Download: 61 Web of Science: 4 Crossref: 2

Case Report

Severe steatohepatitis with hepatic decompensation resulting from malnutrition after pancreaticoduodenectomy

Eun Hui Sim, Jung Hyun Kwon, Se Young Kim, Seung Min Jung, Lee-So Maeng, Jeong Won Jang, Kyu Won Chung

Clin Mol Hepatol. 2012;18(4):404-410. Published online December 21, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.4.404

View: 7248 Download: 83 Crossref: 13

Review

Clinical applications of transient elastography

Kyu Sik Jung, Seung Up Kim

Clin Mol Hepatol. 2012;18(2):163-173. Published online June 26, 2012

DOI: https://doi.org/10.3350/cmh.2012.18.2.163

View: 11624 Download: 121 Crossref: 78

Snapshot

EXAMINING THE THERAPEUTIC LANDSCAPE OF BETA-BLOCKERS IN PORTAL HYPERTENSION

Anna Brujats, Càndid Villanueva

Received February 24, 2024 Accepted March 4, 2024

DOI: https://doi.org/10.3350/cmh.2024.0144 [Accepted]

View: 421 Download: 19

1 |

Viewed By 5362	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5317	MAFLD: How is it different from NAFLD?
Viewed By 5208	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3894	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3853	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 76	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 65	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 52	MAFLD: How is it different from NAFLD?

Search